Heron Therapeutics Inc vs Consumer Discretionary Select Sector SPDR Fund — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while Consumer Discretionary Select Sector SPDR Fund trades at $114.85. The key difference: Consumer Discretionary Select Sector SPDR Fund is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | XLY | |
|---|---|---|
Market Cap | $91.46M | — |
Sector | Health | — |
52-Week High | $1.96 | $124.52 |
52-Week Low | $0.39 | $105.64 |
Enterprise Value | $189.36M | — |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: retail; hotels, restaurants and leisure; textiles, apparel and luxury goods; household durables; automobiles; auto components; distributors; leisure products; and diversified consumer services. It is non-diversified.
Read more on XLY →